16-11-2026 22:04 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Deliverable Volume
Mankind Pharma Ltd.
 
BSE Code 543904
ISIN Demat INE634S01028
Book Value 425.24
NSE Code MANKIND
Dividend Yield % 0.04
Market Cap 1084243.36
P/E 47.07
EPS 55.77
Face Value 1  
Exchange : Period From : Period To :
DateTotal VolumeDeliverable VolumeDeliverable Volume [%]
16-Nov-2026 31971 18918 59.17
13-Nov-2026 34818 24468 70.27
12-Nov-2026 11265 5235 46.47
11-Nov-2026 169012 155278 91.87
09-Nov-2026 81800 26454 32.34
08-Nov-2026 9519 6031 63.36
06-Nov-2026 7382 3106 42.08
05-Nov-2026 20901 12480 59.71
04-Nov-2026 17374 10505 60.46
03-Nov-2026 296880 291745 98.27
02-Nov-2026 8156 3481 42.68
Page 1 of 1
Prev || Next
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.